SAN DIEGO--(BUSINESS WIRE)--
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, President &
Chief Operating Officer, will present an update on the company at the
Canaccord Genuity 34th Annual Growth Conference in Boston,
Massachusetts on Thursday, August 14, 2014 at 1:30pm (EDT). The
presentation, which will occur live at the InterContinental Boston, will
be concurrently webcast.
The link to the webcast will be available on the DexCom website at www.dexcom.com
by navigating to "About," then "Investor Relations," and then "Events
and Webcasts" and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization of the company's products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company's development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company's
quarterly report on Form 10-Q for the quarter ended March 31, 2014, as
filed with the Securities and Exchange Commission on May 1, 2014.
Source: DexCom, Inc.